Preparation of a fludarabine intermediate via selective alkylation of 2-fluoroadenine

Nucleosides, Nucleotides and Nucleic Acids

Volumn 25, Issue 7, 2006, Pages 735-745

  Schulmeier, Brian ^a,b   Cantrell, William ^a   Bauta, William ^a  

^a GENZYME CORPORATION   (United States)

^b Cerillant Corporation   (United States)

Author keywords

Anomeric selectivity; Solvent effects

Indexed keywords

1,3,5 TRI O BENZYL 1 ALPHA DEXTRO CHLOROARABINOFURANOSE; 2 FLUOROADENINE; 7 BETA DEXTRO (2,3,5 TRI O BENZYLARABINOFURANOSYL) 2 FLUOROADENINE; 9 BETA DEXTRO (2,3,5 TRI O BENZYLARABINOFURANOSYL) 2 FLUOROADENINE; ADENINE DERIVATIVE; BENZYL DERIVATIVE; FLUDARABINE; NUCLEOSIDE DERIVATIVE; POTASSIUM DERIVATIVE; SOLVENT; SULFOLANE; SULFUR DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CHEMICAL REACTION; SYNTHESIS;

ADENINE; ALKYLATION; ARABINOSE; NUCLEIC ACID CONFORMATION; PENTANOLS; STEREOISOMERISM; VIDARABINE;

EID: 33746826528     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770600725960     Document Type: Article

References (21)

1. (a) Ferrajoli, A.; Keating, M.J.; O'Brien, S.M. Chemotherapy of Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia, Conference, General Review 2004, 241-254.
2. (b) Plunkett, W.; Gandhi, V.; Huang, P.; Robertson, L.E.; Yang, L.Y.; Gregoire, V.; Estey, E.; Keating, M.J. Fludarabine: Pharmacokinetics, Mechanisms of Action, and Rationales for Combination Therapies. Seminars in Oncology 1993, 20, 2-12.
3. (c) Montgomery, J.A.; Shortnacy, A.T. Prodrug Derivatives of 9(-D-Arabinofuranosyl-2-Fluoroadenine. U. S. Patent 4, 357, 324, 1982.
4. (a) Montgomery, J.A.; Hewson, K. Nucleosides of 2-Fluoroadenine. Journal of Medicinal Chemistry, 1969, 12, 498-504.
5. (b) Montgomery, J.A. Anticancer and antiviral activity of 9-β-D-arabinofuranosyl-2-Fluoroadenine. U.S. Patent 4188378 19800212, 1980.
6. Montgomery, J.A.; Clayton, S.D.; Shortnacy, A.T. An Improved Procedure for the Preparation of 9-β-Arabinofuranosyl-2-Fluoroadenine. Journal of Heterocyclic Chemistry 1979, 16, 157-160.
7. Markovac, A.; Kalamas, R.L.; LaMontagne, M.P. Improved process for the preparation of 2-amino(2,3,5-tri-O-Benzyl-beta-D-Arabinofuranosyl) Adenine, Eur Pat. Appl. 0 578 208 B1 1993.
8. Bauman, J.G.; Wirsching, R.C. Process for the preparation of fludarabine or fludarabine phosphate from guanosine, U.S. Patent US5602246 19921125 1997.
9. Roe, A. Preparation of Aromatic Fluorine Compounds from Diazonium Fluoborates. The Schiemann Reaction. Organic Reactions 1949, 5, 193-228.
10. 2-Fluoroadenine was purchased from Sigma-Aldrich Corporation.
11. Bauta, W.E.; Schulmeier, B.E.; Burke, B.; Puente, J.F.; Cantrell, W.R.; Lovett, D.; Goebel, J.; Anderson, B.; Ionescu, D.; Guo, R. A New Process for Antineoplastic Agent Clofarabine. Organic Process Research & Development 2004, 8, 889-896.
12. (a) LaMontagne, M.P.; Smith, D.C.;Wu, G.S. Preparation of 7-Substituted Pyrrolo[2,3-d]Pyrimidines and 9-Substituted Purines as Potential Antiparasitic Agents. Journal of Heterocyclic Chemistry 1983, 20, 295-299.
13. (b) Holy, A.; Gunter, J.; Dvorakova, H.; Masojidkova, M.; Andrei, G.; Snoeck, R.; Balzarini, J.; De Clercq, E. Structure-Antiviral Activity Relationship in the Series of Pyrimidine and Purine N-[2-(2-Phosphonomethoxy) Ethyl] Nucleotide Analogues. 1. Derivatives Substituted at the Carbon Atoms of the Base. Journal of Medicinal Chemistry 1999, 42, 2064-2086.
14. (a) Friedrich, W.; Bernhaer, K. Contributions to the Chemistry and Biochemistry of Cobalamin. II. The Degradation of Cobalamin with Cerous Hydroxide, 7-(D-Ribofuranosidyl)Adenine, a Degradation Product of Pseudovitamin B12. Chemische Berichte, 1956, 89, 2507-2512.
15. (b) Montgomery, J.A.; Thomas, H.J. 7-Glycosylpurines. I. The Synthesis of the Anomeric 7-D-Ribofuranosyladenines and the Identification of the Nucleoside from Pseudovitamin B1-12. Journal of the American Chemical Society 1965, 87, 5442-5447.
16. (c) Zaitseva, G.V.; Sivets, G.G.; Kazimierczuk, Z.; Vilpo, J.A.; Mikhailopulo, I.A. Convergent Synthesis and Cytostatic Properties of 2-Chloro-2′-Deoxy-2′-Fluoroadenosine and Its N7-Isomer. Bioorganic & Medical Chemistry Letters 1995, 5, 2999-3002.
17. (d) Seela, F.; Winter, H. Synthesis of 6-Substituted Purine N7-(2-Deoxy-β-D-Ribonucleosides) via Anion Glycosylation and Anomerization during the N7/N9-Glycosyl Transfer. Nucleosides & Nucleotides, 1995, 14, 129-142.
18. Reichardt, C. Solvents and Solvent Effects in Organic Chemistry. 2nd Weinheim: VCH, 1988.
19. Dvorko, G.F.; Vasil'kevich, A.I.; Dikhtyar, Y.V.; Ponomareva, E.A. Kinetics and Mechanism of Unimolecular Heterolysis of Carcass Compounds. XV. The Nature of Solvolysis Effects in Heterolysis of 2-Bromo-2-Phenyladamantane in Dipolar Aprotic Solvents. Russian Journal of Organic Chemistry 1999, 35, 522-526.
20. Parker, A.J.; Mayer, U.; Schmid, R.; Gutmann, V. Correlation of Solvent Effects on Rates of Solvolysis and SN2 Reactions. Journal of Organic Chemistry 1978, 43, 1843-1854.
21. Glaudemans, C.P.; Fletcher, H.G. Jr. Long Range Effects of Acyl Groups in the Solvolysis of Glycofuranosyl Halides. The Synthesis of 2,3-di-O-Benzyl-5-O- p-Nitrobenzyl-α-D-Arabinofuranosyl Chloride and 2-O-Benzyl-3,5-di-O-p- Nitrobenzyl-α-D-Arabinofuranosyl Chloride. Journal of the American Chemical Society 1965, 87, 4636-4641.